Pandemic flu vaccine trial 'success'

An influenza vaccine that could help to protect against a possible flu pandemic has achieved positive results in early trials, say UK researchers.

The vaccine, ACAM-FLU-A, made by the biotechnology company Acambis, targets all strains of influenza A, the type responsible for a pandemic.

Preliminary results have shown that the vaccine is well tolerated and immunogenic.

Researchers also tested whether the vaccine could offer protection against avian flu.

Using ferrets, commonly used in flu research because they are susceptible to human and bird flu, they found that 70 per cent of those vaccinated were protected against the H5N1 virus.

Acambis preliminary research 2008 

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus